Abstract:Glucagon-like peptide-2 (GLP-2), an intestinotrophic hormone, has drawn considerable attention worldwide due to its potential to promote intestinal development. We investigated the effects and mechanisms of GLP-2 against lipopolysaccharide (LPS)-induced intestinal inflammation and injury both in vitro and in vivo. Forty healthy piglets weaned at the age of 28 days with similar body weight (BW) were assigned to four in vivo treatments with ten piglets each: (i) nonchallenged control; (ii) LPS-challenged control; (iii) LPS + low dose GLP-2; and (iv) LPS + high dose GLP-2. Piglets were subcutaneously injected with phosphate-buffered saline supplemented with GLP-2 at doses of 0, 0, 2, and 10 nmol/kg BW per day for seven consecutive days. The piglets were challenged with an intraperitoneal injection with 100 mu g/kg LPS on day 14 to induce intestinal damage. After that, the gene and protein expression levels of representative tight junction proteins and myosin light-chain kinase (MLCK)/phosphorylated myosin light chain (pMLC), as well as proinflammatory cytokine levels were determined using quantitative reverse transcription polymerase chain reaction, western blot, and enzyme-linked immunosorbent assay methods. A high dose of GLP-2 pretreatment increased intestinal permeability by downregulating and redistributing tight junction proteins (p < .05), for example, zona occluden-1 (ZO-1) and occludin. GLP-2 decreased the transcription of proinflammatory cytokines genes including interleukin-1 beta (IL-1 beta), IL-6, IL-8, and tumor necrosis factor-alpha in small intestines (p < .05). GLP-2 prevented the LPS-induced increase in the expression of MLCK dose-dependently and the increase in pMLC levels in the duodenum, jejunum, and ileum. To assess further the protective effect of GLP-2 on LPS-induced intestinal barrier injury after weaning and its possible mechanism, an in vitro intestinal epithelial barrier model was established with IPEC-J2 monolayers and treated with 100 mu g/ml LPS with or without 1 x 10(-8) mol/L GLP-2 pretreatment. The in vitro analysis included control, LPS, and GLP-2 + LPS treatments. GLP-2 treatment alleviated the destructive effect of LPS on barrier permeability by restoring the expression and ultrastructure of ZO-1 and occludin (p < .05). In addition, GLP-2 reversed the LPS-induced MLCK hyperexpression and pMLC hyperphosphorylation (p < .05). Taken together, our findings revealed a mechanism by which GLP-2 alleviated LPS-challenged intestinal barrier injury and inflammation in weaned piglets and IPEC-J2 cells via the MLCK/pMLC signaling pathway.

Glucagon‐like Peptide 2 Attenuates Intestinal Mucosal Barrier Injury Through the MLCK/pMLC Signaling Pathway in a Piglet Model

Comparison between <i>Lactobacillus rhamnosus</i> GG and LuxS-deficient strain in regulating gut barrier function and inflammation in early-weaned piglets

Effect of Glucagon-like Peptide 2 on Tight Junction in Jejunal Epithelium of Weaned Pigs Though MAPK Signaling Pathway.

Effects of Glucagon-Like Peptide-2 Supplementation on Expression of Intestinal Epithelial Tight Junction Protein Related Genes in Weaner Piglets in Vitro

The Prolonged Effect of Glucagon-Like Peptide 2 Pretreatment on Growth Performance and Intestinal Development of Weaned Piglets.

Effects of Glucagon-like Peptide-2 on Morphology, Proliferation and Enzyme Activity of Intestinal Enterocyte Cells of Weaned Piglets in Vitro

Glucagon-Like Peptide-2 Modulates Enteric Paneth Cells Immune Response and Alleviates Gut Inflammation During Intravenous Fluid Infusion in Mice With a Central Catheter

Inhibitors of Mitogen Activated Protein Kinase Pathways: Effects on Intestinal Morphology and Permeability of Weaner Piglets

Lactobacillus Rhamnosus GG Attenuates Lipopolysaccharide-Induced Inflammation and Barrier Dysfunction by Regulating MAPK/NF-ĸB Signaling and Modulating Metabolome in the Piglet Intestine

Lactobacillus rhamnosus GG Attenuates Lipopolysaccharide-Induced Inflammation and Barrier Dysfunction by Regulating MAPK/NF-κB Signaling and Modulating Metabolome in the Piglet Intestine.

Effects of Alanyl-Glutamine Supplementation on the Small Intestinal Mucosa Barrier in Weaned Piglets Challenged with Lipopolysaccharide

Cytoprotection and Repairing Effects of GLP-2 on Intestinal Epithelial Cells of 28-D Weaned Piglets Injuried by Β-Conglycinin in Vitro

L-Cysteine Protects Intestinal Integrity, Attenuates Intestinal Inflammation And Oxidant Stress, And Modulates Nf-B And Nrf2 Pathways In Weaned Piglets After Lps Challenge

Lps Challenge Increased Intestinal Permeability, Disrupted Mitochondrial Function And Triggered Mitophagy Of Piglets

Glutamate alleviates intestinal injury, maintains mTOR and suppresses TLR4 and NOD signaling pathways in weanling pigs challenged with lipopolysaccharide

Effects of Glucagon-like Peptide 2 (GLP-2) on Morphology Proliferation Function and Enzyme Activity of Small Intestinal Epithelial Cell of Weaning Pig in Vitro

The Synbiotic Mixture of Lactulose and Bacillus Coagulans Protects Intestinal Barrier Dysfunction and Apoptosis in Weaned Piglets Challenged with Lipopolysaccharide.

Dietary alpha-ketoglutarate supplementation ameliorates intestinal injury in lipopolysaccharide-challenged piglets.

Dietary α-ketoglutarate supplementation ameliorates intestinal injury in lipopolysaccharide-challenged piglets

Glucagonlike peptide 2 protects intestinal barrier in severe acute pancreatitis through regulating intestinal epithelial cell proliferation and apoptosis.

Pectin supplementation ameliorates intestinal epithelial barrier function damage by modulating intestinal microbiota in lipopolysaccharide-challenged piglets